Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $173
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $191 to $173.
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $191 to $173.